Lido Advisors LLC boosted its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 172.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 30,147 shares of the pharmacy operator’s stock after buying an additional 19,091 shares during the period. Lido Advisors LLC’s holdings in Walgreens Boots Alliance were worth $1,202,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the stock. State Street Corp boosted its position in Walgreens Boots Alliance by 2.5% in the 3rd quarter. State Street Corp now owns 46,444,706 shares of the pharmacy operator’s stock worth $1,668,294,000 after purchasing an additional 1,115,564 shares in the last quarter. Morgan Stanley boosted its position in Walgreens Boots Alliance by 10.2% in the 3rd quarter. Morgan Stanley now owns 7,460,256 shares of the pharmacy operator’s stock worth $267,973,000 after purchasing an additional 691,989 shares in the last quarter. Thornburg Investment Management Inc. boosted its position in Walgreens Boots Alliance by 0.6% in the 3rd quarter. Thornburg Investment Management Inc. now owns 5,879,078 shares of the pharmacy operator’s stock worth $211,176,000 after purchasing an additional 36,830 shares in the last quarter. UBS Asset Management Americas Inc. boosted its position in Walgreens Boots Alliance by 2.8% in the 3rd quarter. UBS Asset Management Americas Inc. now owns 4,440,786 shares of the pharmacy operator’s stock worth $159,513,000 after purchasing an additional 120,022 shares in the last quarter. Finally, ProShare Advisors LLC boosted its position in Walgreens Boots Alliance by 20.0% in the 3rd quarter. ProShare Advisors LLC now owns 3,193,690 shares of the pharmacy operator’s stock worth $114,717,000 after purchasing an additional 531,981 shares in the last quarter. Hedge funds and other institutional investors own 55.96% of the company’s stock.

Several research firms have commented on WBA. Truist Financial upped their price objective on Walgreens Boots Alliance from $40.00 to $44.00 in a research report on Tuesday, January 5th. Barclays increased their price objective on Walgreens Boots Alliance from $40.00 to $47.00 and gave the company an “equal weight” rating in a research note on Friday, January 8th. TheStreet downgraded Walgreens Boots Alliance from a “b-” rating to a “c” rating in a research note on Thursday, January 7th. Guggenheim raised Walgreens Boots Alliance from a “neutral” rating to a “buy” rating and set a $55.00 price objective for the company in a research note on Monday, January 11th. Finally, Robert W. Baird upgraded Walgreens Boots Alliance from a “neutral” rating to an “outperform” rating and upped their target price for the company from $41.00 to $55.00 in a report on Monday, January 11th. Two research analysts have rated the stock with a sell rating, fourteen have issued a hold rating and two have given a buy rating to the stock. The stock presently has a consensus rating of “Hold” and an average target price of $44.50.

Walgreens Boots Alliance stock opened at $48.86 on Tuesday. The stock’s 50 day moving average price is $48.43 and its 200 day moving average price is $41.00. The company has a market cap of $42.22 billion, a PE ratio of 97.72, a price-to-earnings-growth ratio of 1.52 and a beta of 0.44. Walgreens Boots Alliance, Inc. has a 1-year low of $33.36 and a 1-year high of $55.49. The company has a debt-to-equity ratio of 0.58, a current ratio of 0.67 and a quick ratio of 0.32.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings results on Wednesday, January 6th. The pharmacy operator reported $1.22 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.03 by $0.19. Walgreens Boots Alliance had a return on equity of 18.33% and a net margin of 0.33%. The company had revenue of $36.31 billion during the quarter, compared to analysts’ expectations of $35.01 billion. During the same period in the previous year, the firm posted $1.37 earnings per share. The business’s revenue for the quarter was up 5.7% compared to the same quarter last year. On average, equities research analysts anticipate that Walgreens Boots Alliance, Inc. will post 4.84 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Friday, March 12th. Stockholders of record on Friday, February 19th will be issued a $0.4675 dividend. The ex-dividend date of this dividend is Thursday, February 18th. This represents a $1.87 dividend on an annualized basis and a dividend yield of 3.83%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is 39.45%.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and beauty retail company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores.

See Also: What is the S&P/ASX 200 Index?

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.